530 related articles for article (PubMed ID: 25152896)
1. Cellular signaling and production of galactose-deficient IgA1 in IgA nephropathy, an autoimmune disease.
Reily C; Ueda H; Huang ZQ; Mestecky J; Julian BA; Willey CD; Novak J
J Immunol Res; 2014; 2014():197548. PubMed ID: 25152896
[TBL] [Abstract][Full Text] [Related]
2. IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy.
Novak J; Julian BA; Tomana M; Mestecky J
Semin Nephrol; 2008 Jan; 28(1):78-87. PubMed ID: 18222349
[TBL] [Abstract][Full Text] [Related]
3. Aberrant glycosylation of IgA1 and anti-glycan antibodies in IgA nephropathy: role of mucosal immune system.
Novak J; Moldoveanu Z; Julian BA; Raska M; Wyatt RJ; Suzuki Y; Tomino Y; Gharavi AG; Mestecky J; Suzuki H
Adv Otorhinolaryngol; 2011; 72():60-3. PubMed ID: 21865691
[TBL] [Abstract][Full Text] [Related]
4. Aberrant Glycosylation of the IgA1 Molecule in IgA Nephropathy.
Novak J; Barratt J; Julian BA; Renfrow MB
Semin Nephrol; 2018 Sep; 38(5):461-476. PubMed ID: 30177018
[TBL] [Abstract][Full Text] [Related]
5. Glomerular Immunodeposits of Patients with IgA Nephropathy Are Enriched for IgG Autoantibodies Specific for Galactose-Deficient IgA1.
Rizk DV; Saha MK; Hall S; Novak L; Brown R; Huang ZQ; Fatima H; Julian BA; Novak J
J Am Soc Nephrol; 2019 Oct; 30(10):2017-2026. PubMed ID: 31444275
[TBL] [Abstract][Full Text] [Related]
6. Cytokines and Production of Aberrantly
Person T; King RG; Rizk DV; Novak J; Green TJ; Reily C
J Interferon Cytokine Res; 2022 Jul; 42(7):301-315. PubMed ID: 35793525
[TBL] [Abstract][Full Text] [Related]
7. Paradigm shift in activity assessment of IgA nephropathy - optimizing the next generation of diagnostic and therapeutic maneuvers via glycan targeting.
Suzuki Y; Suzuki H; Yasutake J; Tomino Y
Expert Opin Biol Ther; 2015 Apr; 15(4):583-93. PubMed ID: 25604055
[TBL] [Abstract][Full Text] [Related]
8. Galactosylation of IgA1 Is Associated with Common Variation in
Gale DP; Molyneux K; Wimbury D; Higgins P; Levine AP; Caplin B; Ferlin A; Yin P; Nelson CP; Stanescu H; Samani NJ; Kleta R; Yu X; Barratt J
J Am Soc Nephrol; 2017 Jul; 28(7):2158-2166. PubMed ID: 28209808
[TBL] [Abstract][Full Text] [Related]
9. Sparsentan ameliorates glomerular hypercellularity and inflammatory-gene networks induced by IgA1-IgG immune complexes in a mouse model of IgA nephropathy.
Reily C; Moldoveanu Z; Pramparo T; Hall S; Huang ZQ; Rice T; Novak L; Komers R; Jenkinson CP; Novak J
Am J Physiol Renal Physiol; 2024 May; 326(5):F862-F875. PubMed ID: 38511222
[TBL] [Abstract][Full Text] [Related]
10. Recognition of galactose-deficient O-glycans in the hinge region of IgA1 by N-acetylgalactosamine-specific snail lectins: a comparative binding study.
Gomes MM; Suzuki H; Brooks MT; Tomana M; Moldoveanu Z; Mestecky J; Julian BA; Novak J; Herr AB
Biochemistry; 2010 Jul; 49(27):5671-82. PubMed ID: 20507092
[TBL] [Abstract][Full Text] [Related]
11. Cytokines alter IgA1 O-glycosylation by dysregulating C1GalT1 and ST6GalNAc-II enzymes.
Suzuki H; Raska M; Yamada K; Moldoveanu Z; Julian BA; Wyatt RJ; Tomino Y; Gharavi AG; Novak J
J Biol Chem; 2014 Feb; 289(8):5330-9. PubMed ID: 24398680
[TBL] [Abstract][Full Text] [Related]
12. IgA glycosylation and immune complex formation in IgAN.
Suzuki H; Novak J
Semin Immunopathol; 2021 Oct; 43(5):669-678. PubMed ID: 34570260
[TBL] [Abstract][Full Text] [Related]
13. The Origin and Activities of IgA1-Containing Immune Complexes in IgA Nephropathy.
Knoppova B; Reily C; Maillard N; Rizk DV; Moldoveanu Z; Mestecky J; Raska M; Renfrow MB; Julian BA; Novak J
Front Immunol; 2016; 7():117. PubMed ID: 27148252
[TBL] [Abstract][Full Text] [Related]
14. IgA nephropathy and Henoch-Schoenlein purpura nephritis: aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cells.
Novak J; Moldoveanu Z; Renfrow MB; Yanagihara T; Suzuki H; Raska M; Hall S; Brown R; Huang WQ; Goepfert A; Kilian M; Poulsen K; Tomana M; Wyatt RJ; Julian BA; Mestecky J
Contrib Nephrol; 2007; 157():134-8. PubMed ID: 17495451
[TBL] [Abstract][Full Text] [Related]
15. Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity.
Suzuki H; Fan R; Zhang Z; Brown R; Hall S; Julian BA; Chatham WW; Suzuki Y; Wyatt RJ; Moldoveanu Z; Lee JY; Robinson J; Tomana M; Tomino Y; Mestecky J; Novak J
J Clin Invest; 2009 Jun; 119(6):1668-77. PubMed ID: 19478457
[TBL] [Abstract][Full Text] [Related]
16. Experimental evidence of pathogenic role of IgG autoantibodies in IgA nephropathy.
Moldoveanu Z; Suzuki H; Reily C; Satake K; Novak L; Xu N; Huang ZQ; Knoppova B; Khan A; Hall S; Yanagawa H; Brown R; Winstead CJ; O'Quinn DB; Weinmann A; Gharavi AG; Kiryluk K; Julian BA; Weaver CT; Suzuki Y; Novak J
J Autoimmun; 2021 Mar; 118():102593. PubMed ID: 33508637
[TBL] [Abstract][Full Text] [Related]
17. Pathogenic role of glycan-specific IgG antibodies in IgA nephropathy.
Zhao YF; Zhu L; Liu LJ; Shi SF; Lv JC; Zhang H
BMC Nephrol; 2017 Sep; 18(1):301. PubMed ID: 28969604
[TBL] [Abstract][Full Text] [Related]
18. Phosphatase control of cytokine-mediated overproduction of galactose-deficient IgA1, the main autoantigen in IgA nephropathy.
Reily C; Rice T; Crossman DK; Rizk DV
J Autoimmun; 2022 Oct; 132():102883. PubMed ID: 35987175
[TBL] [Abstract][Full Text] [Related]
19. Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy.
Gharavi AG; Moldoveanu Z; Wyatt RJ; Barker CV; Woodford SY; Lifton RP; Mestecky J; Novak J; Julian BA
J Am Soc Nephrol; 2008 May; 19(5):1008-14. PubMed ID: 18272841
[TBL] [Abstract][Full Text] [Related]
20. IL-6 and its role in IgA nephropathy development.
Groza Y; Jemelkova J; Kafkova LR; Maly P; Raska M
Cytokine Growth Factor Rev; 2022 Aug; 66():1-14. PubMed ID: 35527168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]